Register
Login

Trending Topic

15 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Cardiovascular disease (CVD) continues to be the primary cause of mortality and morbidity globally with middle-aged women presenting with additional and possibly, overlooked risk factors.1 Despite several awareness programmes, there remain several gaps in the political education and representation needs of this group, which includes those from low socioeconomic status (SES) and culturally diverse backgrounds. These […]

Luigi Di Biase, AFS 2022: Peri and post procedural anticoagulation with LAA closure devices

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 24th 2022

The advantages and challenges of peri and post procedural anticoagulation with LAA closure devices were discussed by Prof. Luigi Di Biase in a short interview with touchCARDIO, at the annual AF Symposium 2022.

The abstract entitled ‘Peri and Post Procedural Anticoagulation with LAA Closure Devices – An Evolving Story’ was presented at the annual AF Symposium, January 13-15, 2022.

Questions:

  1. What are the advantages and disadvantages of left atrial appendage (LAA) closure as opposed to the use of direct-acting oral anticoagulants in high-risk patients with atrial fibrillation? (0:15)
  2. Why is peri-and post-procedural anticoagulants needed with LAA closure devices? (1:19)
  3. What are the challenges of peri-and post-procedural anticoagulants with LAA closure devices? (2:21)
  4. What have we learned about optimal peri- and post-procedural anticoagulation in this clinical scenario? (3:18)
  5. What questions remain unanswered and what further research is needed? (4:28)

Disclosures: Luigi Di Biase has nothing to disclose in relation to this video interview

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.

Filmed as a highlight of AFS 2022

Click here for more content from Prof. Luigi Di Biase.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup